Association between maternal acetaminophen use and adverse birth outcomes in a pregnancy and birth cohort

Abstract

Introduction

Acetaminophen is the only analgesic recommended for use during pregnancy. This use has recently been linked to childhood developmental disorders, a finding that requires further investigation. Adverse birth outcomes—preterm birth, low birthweight, and small for gestational age—are associated with increased risk of developmental disorders and can serve as intermediate outcomes when examining the impact of maternal acetaminophen use.

Methods

Clinical and lifestyle-factor data were gathered from 1200 women within the Ontario Birth Study who delivered between January 2013 and June 2017. Poisson regression with robust error variance was used to estimate the relationship between acetaminophen use before and during pregnancy and low birthweight, preterm birth, and small for gestational age.

Results

Offspring of mothers who used acetaminophen before pregnancy had a higher risk of low birthweight and small for gestational age. Acetaminophen use <once/week was associated with small for gestational age, adjusted relative risk (aRR) = 1.46 (95% CI 1.02, 2.11). Acetaminophen use ≥once/week was associated with both small for gestational age, RR = 1.82 (95% CI 1.12, 2.94), and low birthweight, aRR = 2.16 (95% CI 1.02, 4.54). Acetaminophen use during pregnancy was not associated with the examined outcomes.

Conclusions

Prepregnancy acetaminophen use may be associated with higher risk of adverse birth outcomes.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    Hernandez, R. K. et al. Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am. J. Obset. Gynecol. 206, 228.e221–228 (2012).

  2. 2.

    Nezvalova-Henriksen, K., Spigset, O. & Nordeng, H. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG 120, 948–959 (2013).

  3. 3.

    Schoenfeld, A., Bar, Y., Merlob, P. & Ovadia, Y. Nsaids: maternal and fetal considerations. Am. J. Reprod. Immunol. 28, 141–147 (1992).

  4. 4.

    Babb, M., Koren, G. & Einarson, A. Treating pain during pregnancy. Can. Fam. Physician 56, 25–27 (2010).

  5. 5.

    Werler, M. M., Mitchell, A. A., Hernandez-Diaz, S. & Honein, M. A. Use of over-the-counter medications during pregnancy. Am. J. Obset. Gynecol. 193, 771–777 (2005).

  6. 6.

    Liew, Z., Ritz, B., Rebordosa, C., Lee, P. C. & Olsen, J. Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr. 168, 313–320 (2014).

  7. 7.

    Liew, Z., Ritz, B., Virk, J., Arah, O. A. & Olsen, J. Prenatal use of acetaminophen and child iq a danish cohort study. Epidemiology 27, 912–918 (2016).

  8. 8.

    Vlenterie, R. et al. Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched cohort study. Int. J. Epidemiol. 45, 1998–2008 (2016).

  9. 9.

    Thompson, J. M. et al. Associations between acetaminophen use during pregnancy and adhd symptoms measured at ages 7 and 11 years. PLoS ONE 9, e108210 (2014).

  10. 10.

    Stergiakouli, E., Thapar, A. & Davey Smith, G. Association of acetaminophen use during pregnancy with behavioral problems in childhood: Evidence against confounding. JAMA Pediatr. 170, 964–970 (2016).

  11. 11.

    Petersen, T. G. et al. Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child. Int. J. Epidemiol. 47, 121–130 (2018).

  12. 12.

    Liew, Z., Bach, C. C., Asarnow, R. F., Ritz, B. & Olsen, J. Paracetamol use during pregnancy and attention and executive function in offspring at age 5 years. Int. J. Epidemiol. 45, 2009–2017 (2016).

  13. 13.

    Hoover, R. M., Hayes, V. A. & Erramouspe, J. Association between prenatal acetaminophen exposure and future risk of attention deficit/hyperactivity disorder in children. Ann. Pharmacother. 49, 1357–1361 (2015).

  14. 14.

    Laue, H. E. et al. Association between meconium acetaminophen and childhood neurocognitive development in geste, a canadian cohort study. Toxicol. Sci. 167, 138–144 (2019).

  15. 15.

    Momany, A. M., Kamradt, J. M. & Nikolas, M. A. A meta-analysis of the association between birth weight and attention deficit hyperactivity disorder. J. Abnorm. Child Psych. 46, 1409–1426 (2018).

  16. 16.

    Liu, L. et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379, 2151–2161 (2012).

  17. 17.

    Rebordosa, C., Kogevinas, M., Bech, B. H., Sorensen, H. T. & Olsen, J. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. Int. J. Epidemiol. 38, 706–714 (2009).

  18. 18.

    Anderson, L. N. et al. The ontario birth study: a prospective pregnancy cohort study integrating perinatal research into clinical care. Paediatr. Perinat. Epidemiol. 32, 290–301 (2018).

  19. 19.

    World Health Organization. Preterm Birth (World Health Organization, 2018).

  20. 20.

    United Nations Children's Fund, World Health Organization. Low Birthweight: Country, Regional and Global Estimates (UNICEF, New York, 2004).

  21. 21.

    Ballot, D. E., Potterton, J., Chirwa, T., Hilburn, N. & Cooper, P. A. Developmental outcome of very low birth weight infants in a developing country. BMC Pediatr. 12, 11 (2012).

  22. 22.

    Kramer, M. S. et al. A new and improved population-based canadian reference for birth weight for gestational age. Pediatrics 108, E35 (2001).

  23. 23.

    Nomura, Y., Marks, D. J. & Halperin, J. M. Prenatal exposure to maternal and paternal smoking on attention deficit hyperactivity disorders symptoms and diagnosis in offspring. J. Nerv. Ment. Dis. 198, 672–678 (2010).

  24. 24.

    Rosenberg, T. J., Garbers, S., Lipkind, H. & Chiasson, M. A. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: Differences among 4 racial/ethnic groups. Am. J. Public Health 95, 1545–1551 (2005).

  25. 25.

    Shapiro, G. D. et al. Paternal education and adverse birth outcomes in canada. J. Epidemiol. Community Health 71, 67–72 (2017).

  26. 26.

    Mumford, S. L., Michels, K. A., Salaria, N., Valanzasca, P. & Belizan, J. M. Preconception care: it's never too early. Reprod. Health 11, 73 (2014).

  27. 27.

    Bauer, A. Z., Kriebel, D., Herbert, M. R., Bornehag, C. G. & Swan, S. H. Prenatal paracetamol exposure and child neurodevelopment: a review. Horm. Behav. 101, 125–147 (2018).

  28. 28.

    Brandlistuen, R. E., Ystrom, E., Nulman, I., Koren, G. & Nordeng, H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int. J. Epidemiol. 42, 1702–1713 (2013).

  29. 29.

    Bornehag, C. G. et al. Prenatal exposure to acetaminophen and children's language development at 30 months. Eur. Psychiat. 51, 98–103 (2018).

  30. 30.

    Masarwa, R. et al. Prenatal exposure to acetaminophen and risk for attention deficit hyperactivity disorder and autistic spectrum disorder: a systematic review, meta-analysis, and meta-regression analysis of cohort studies. Am. J. Epidemiol. 187, 1817–1827 (2018).

  31. 31.

    Thiele, K., Kessler, T., Arck, P., Erhardt, A. & Tiegs, G. Acetaminophen and pregnancy: short- and long-term consequences for mother and child. Am. J. Reprod. Immunol. 97, 128–139 (2013).

  32. 32.

    Anderson, B. J. Paracetamol (acetaminophen): mechanisms of action. Paediatr. Anaesth. 18, 915–921 (2008).

  33. 33.

    Li, D., Ferber, J. R., Odouli, R. & Quesenberry, C. Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage. Am. J. Obstet. Gynecol. 219, 275.e1–275.e8 (2018).

  34. 34.

    Lind, D. V. et al. Maternal use of mild analgesics during pregnancy associated with reduced anogenital distance in sons: a cohort study of 1027 mother-child pairs. Hum. Reprod. 32, 223–231 (2017).

  35. 35.

    Dean, A. et al. Analgesic exposure in pregnant rats affects fetal germ cell development with inter-generational reproductive consequences. Sci. Rep. 6, 19789 (2016).

  36. 36.

    McInerney, K. A. et al. Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study. Hum. Reprod. 32, 103–111 (2017).

  37. 37.

    Smarr, M. M. et al. Urinary paracetamol and time-to-pregnancy. Hum. Reprod. 31, 2119–2127 (2016).

  38. 38.

    Statistics Canada. Education in Canada: Key Results from the 2016 Census (Statistics Canada, 2017).

  39. 39.

    Statistics Canada. Fertility: Fewer Children, Older Moms (Statistics Canada, 2014).

  40. 40.

    Patra, J. et al. Dose−response relationship between alcohol consumption before and during pregnancy and the risks of low birthweight, preterm birth and small for gestational age (SGA)—a systematic review and meta-analyses. BJOG 118, 1411–1421 (2011).

Download references

Acknowledgements

The authors would like to thank the participants of the Ontario Birth Study. This work was supported by funding from the Dalla Lana School of Public Health at the University of Toronto, the Lunenfeld−Tanenbaum Research Institute, Mount Sinai Hospital Women’s Auxiliary, through a grant to S.J.L., and the Department of Obstetrics and Gynecology at Mount Sinai Hospital. Additional funding was provided by the Canadian Institute of Health Research through a grant to S.J.L. (FDN‐143262).

Author information

Affiliations

Authors

Contributions

All authors (J.A., R.J.H., R.A.S., J.A.K., S.L.H., A.B., S.J.L., and J.D.B.) have met the Pediatric Research requirements for authorship. All authors (J.A., R.J.H., R.A.S., J.A.K., S.L.H., A.B., S.J.L., and J.D.B.) made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafted the article or revised it critically for important intellectual content; and provided final approval of the version to be published.

Corresponding author

Correspondence to Jennifer D. Brooks.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Arneja, J., Hung, R.J., Seeto, R.A. et al. Association between maternal acetaminophen use and adverse birth outcomes in a pregnancy and birth cohort. Pediatr Res (2019). https://doi.org/10.1038/s41390-019-0726-8

Download citation